On Friday, August 15, the FDA approved Wegovy (semaglutide) as the first-ever GLP-1 therapy for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) — a pivotal moment in the fight ...
As with other prescription drugs, you’ll get the most out of it if you understand how it works and what to expect. Find out more about when and how to use semaglutide so it can improve your liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results